array:25 [
  "pii" => "S021169951730187X"
  "issn" => "02116995"
  "doi" => "10.1016/j.nefro.2017.09.003"
  "estado" => "S300"
  "fechaPublicacion" => "2018-05-01"
  "aid" => "425"
  "copyright" => "Sociedad Española de Nefrología"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2018;38:286-96"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 8213
    "formatos" => array:3 [
      "EPUB" => 409
      "HTML" => 6895
      "PDF" => 909
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:20 [
      "pii" => "S2013251418300166"
      "issn" => "20132514"
      "doi" => "10.1016/j.nefroe.2017.09.010"
      "estado" => "S300"
      "fechaPublicacion" => "2018-05-01"
      "aid" => "425"
      "copyright" => "Sociedad Española de Nefrología"
      "documento" => "article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia (English Version). 2018;38:286-96"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 3145
        "formatos" => array:3 [
          "EPUB" => 280
          "HTML" => 2289
          "PDF" => 576
        ]
      ]
      "en" => array:13 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>"
        "titulo" => "Atrial fibrillation in patients on haemodialysis in Andalusia&#46; Prevalence&#44; clinical profile and therapeutic management"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => array:2 [
          0 => "en"
          1 => "es"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "286"
            "paginaFinal" => "296"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Fibrilaci&#243;n auricular en los pacientes en hemodi&#225;lisis en Andaluc&#237;a&#46; Prevalencia&#44; perfil cl&#237;nico y manejo terap&#233;utico"
          ]
        ]
        "contieneResumen" => array:2 [
          "en" => true
          "es" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:7 [
            "identificador" => "fig0010"
            "etiqueta" => "Fig&#46; 2"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr2.jpeg"
                "Alto" => 1522
                "Ancho" => 2333
                "Tamanyo" => 146716
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Prevalence of AF in the general population &#40;OFRECE 9 study&#41; and in dialysis patients &#40;FAIRC study in Andalusia&#41;&#46; Data It is shown as prevalence&#44; total and separated by ranges of age&#46; The OFRECE9 study included patients aged 40 years or older&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Carmen S&#225;nchez Perales, Teresa V&#225;zquez S&#225;nchez, Daniel Salas Bravo, Sonia Ortega Anguiano, Eduardo V&#225;zquez Ruiz de Castroviejo"
            "autores" => array:6 [
              0 => array:2 [
                "nombre" => "Carmen"
                "apellidos" => "S&#225;nchez Perales"
              ]
              1 => array:2 [
                "nombre" => "Teresa"
                "apellidos" => "V&#225;zquez S&#225;nchez"
              ]
              2 => array:2 [
                "nombre" => "Daniel"
                "apellidos" => "Salas Bravo"
              ]
              3 => array:2 [
                "nombre" => "Sonia"
                "apellidos" => "Ortega Anguiano"
              ]
              4 => array:2 [
                "nombre" => "Eduardo"
                "apellidos" => "V&#225;zquez Ruiz de Castroviejo"
              ]
              5 => array:1 [
                "colaborador" => "en representaci&#243;n de los investigadores del estudio FAIRC Andaluc&#237;a"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "es" => array:9 [
          "pii" => "S021169951730187X"
          "doi" => "10.1016/j.nefro.2017.09.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "es"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951730187X?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418300166?idApp=UINPBA000064"
      "url" => "/20132514/0000003800000003/v1_201805170414/S2013251418300166/v1_201805170414/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S0211699517301856"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2017.08.006"
    "estado" => "S300"
    "fechaPublicacion" => "2018-05-01"
    "aid" => "423"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2018;38:297-303"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5471
      "formatos" => array:3 [
        "EPUB" => 361
        "HTML" => 4237
        "PDF" => 873
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Validaci&#243;n del KDRI&#47;KPDI para la selecci&#243;n de donantes renales con criterios expandidos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "297"
          "paginaFinal" => "303"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Validation of KDRI&#47;KDPI for the selection of expanded criteria kidney donors"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 2441
              "Ancho" => 2909
              "Tamanyo" => 352796
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Curvas de supervivencia estratificadas por los <span class="elsevierStyleItalic">scores</span> KDPI y KDRI en diferentes puntos de corte&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Raimundo M Garc&#237;a del Moral Mart&#237;n, Juan Antonio Retamero D&#237;az, Mercedes Cava Molina, Belen M&#46; Cobacho Tornel, Juan Bravo Soto, Antonio Osuna Ortega, Francisco O&#8217;Valle Ravassa"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "Raimundo M Garc&#237;a"
              "apellidos" => "del Moral Mart&#237;n"
            ]
            1 => array:2 [
              "nombre" => "Juan Antonio"
              "apellidos" => "Retamero D&#237;az"
            ]
            2 => array:2 [
              "nombre" => "Mercedes"
              "apellidos" => "Cava Molina"
            ]
            3 => array:2 [
              "nombre" => "Belen M&#46;"
              "apellidos" => "Cobacho Tornel"
            ]
            4 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Bravo Soto"
            ]
            5 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "Osuna Ortega"
            ]
            6 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "O&#8217;Valle Ravassa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251417302183"
        "doi" => "10.1016/j.nefroe.2017.12.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251417302183?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517301856?idApp=UINPBA000064"
    "url" => "/02116995/0000003800000003/v2_201810040615/S0211699517301856/v2_201810040615/es/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S0211699517302114"
    "issn" => "02116995"
    "doi" => "10.1016/j.nefro.2017.09.011"
    "estado" => "S300"
    "fechaPublicacion" => "2018-05-01"
    "aid" => "435"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2018;38:279-85"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4191
      "formatos" => array:3 [
        "EPUB" => 293
        "HTML" => 2889
        "PDF" => 1009
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Influencia de la sobrecarga de calcio sobre el metabolismo &#243;seo y mineral en 55 centros de hemodi&#225;lisis de Lima"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "279"
          "paginaFinal" => "285"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Impact of calcium overload on bone and mineral metabolism at 55 hemodialysis centers in Lima"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1614
              "Ancho" => 1044
              "Tamanyo" => 96488
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Porcentaje de pacientes en los rangos recomendados por las gu&#237;as KDOQI &#40;A&#41; y KDIGO &#40;B&#41;&#46;</p> <p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Los rangos recomendados por las gu&#237;as KDOQI son calcio corregido por alb&#250;mina&#58; 8&#44;4-9&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#44; f&#243;sforo&#58; 3&#44;5-5&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl y PTH&#58; 150-300 pg&#47;ml<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">13</span></a> y por las gu&#237;as KDIGO&#44; calcio&#58; valores normales 8&#44;5-10&#44;2<span class="elsevierStyleHsp" style=""></span>mg&#47;dl&#44; f&#243;sforo&#58; valores normales 3&#44;0-4&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;dl y PTH&#58; 2 a 9 veces el valor m&#225;ximo de la normalidad 130-585<span class="elsevierStyleHsp" style=""></span>pg&#47;ml<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">14</span></a>&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Pedro M&#233;ndez-Chac&#243;n, Nicol&#225;s Riccobelli, Mar&#237;a P&#46; Dionisi, Emilio S&#225;nchez-&#193;lvarez, Fernando Bardales-Viguria, Carla M&#233;ndez-Chac&#243;n Rodr&#237;guez, Jorge B&#46; Cannata-And&#237;a, Jos&#233; L&#46; Fern&#225;ndez-Mart&#237;n"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "Pedro"
              "apellidos" => "M&#233;ndez-Chac&#243;n"
            ]
            1 => array:2 [
              "nombre" => "Nicol&#225;s"
              "apellidos" => "Riccobelli"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a P&#46;"
              "apellidos" => "Dionisi"
            ]
            3 => array:2 [
              "nombre" => "Emilio"
              "apellidos" => "S&#225;nchez-&#193;lvarez"
            ]
            4 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Bardales-Viguria"
            ]
            5 => array:2 [
              "nombre" => "Carla"
              "apellidos" => "M&#233;ndez-Chac&#243;n Rodr&#237;guez"
            ]
            6 => array:2 [
              "nombre" => "Jorge B&#46;"
              "apellidos" => "Cannata-And&#237;a"
            ]
            7 => array:2 [
              "nombre" => "Jos&#233; L&#46;"
              "apellidos" => "Fern&#225;ndez-Mart&#237;n"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S2013251418300555"
        "doi" => "10.1016/j.nefroe.2018.03.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418300555?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699517302114?idApp=UINPBA000064"
    "url" => "/02116995/0000003800000003/v2_201810040615/S0211699517302114/v2_201810040615/es/main.assets"
  ]
  "es" => array:21 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
    "titulo" => "Fibrilaci&#243;n auricular en los pacientes en hemodi&#225;lisis en Andaluc&#237;a&#46; Prevalencia&#44; perfil cl&#237;nico y manejo terap&#233;utico"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "286"
        "paginaFinal" => "296"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Carmen S&#225;nchez Perales, Teresa V&#225;zquez S&#225;nchez, Daniel Salas Bravo, Sonia Ortega Anguiano, Eduardo V&#225;zquez Ruiz de Castroviejo"
        "autores" => array:6 [
          0 => array:4 [
            "nombre" => "Carmen"
            "apellidos" => "S&#225;nchez Perales"
            "email" => array:1 [
              0 => "mcsanchezp&#64;senefro&#46;org"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Teresa"
            "apellidos" => "V&#225;zquez S&#225;nchez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Daniel"
            "apellidos" => "Salas Bravo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Sonia"
            "apellidos" => "Ortega Anguiano"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Eduardo"
            "apellidos" => "V&#225;zquez Ruiz de Castroviejo"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          5 => array:2 [
            "colaborador" => "en representaci&#243;n de los investigadores del estudio FAIRC Andaluc&#237;a"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#9674;</span>"
                "identificador" => "fn0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Unidad de Gesti&#243;n Cl&#237;nica de Nefrolog&#237;a&#44; Complejo Hospitalario de Ja&#233;n&#44; Ja&#233;n&#44; Espa&#241;a"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Unidad de Gesti&#243;n Cl&#237;nica de Nefrolog&#237;a&#44; Hospital Regional Universitario de M&#225;laga&#44; M&#225;laga&#44; Espa&#241;a"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidad de Gesti&#243;n Cl&#237;nica de Cardiolog&#237;a&#44; Complejo Hospitalario de Ja&#233;n&#44; Ja&#233;n&#44; Espa&#241;a"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspondencia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Atrial fibrillation in patients on haemodialysis in Andalusia&#46; Prevalence&#44; clinical profile and therapeutic management"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1522
            "Ancho" => 2333
            "Tamanyo" => 146621
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Diferencias en la prevalencia de FA entre la poblaci&#243;n general&#44; estudio OFRECE<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a> y pacientes en di&#225;lisis del estudio FAIRC Andaluc&#237;a&#46; Se muestra en prevalencia total y por franjas de edad&#46;</p> <p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">El estudio OFRECE<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a> incluy&#243; poblaci&#243;n con edad igual o mayor de 40 a&#241;os&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introducci&#243;n</span><p id="par0005" class="elsevierStylePara elsevierViewall">La fibrilaci&#243;n auricular &#40;FA&#41; es la arritmia sostenida m&#225;s relevante desde el punto de vista social y sanitario&#46; Su elevada frecuencia&#44; su capacidad trombog&#233;nica y la necesidad de establecer medidas para la prevenci&#243;n de sus complicaciones la convierten en una enfermedad que requiere una importante asignaci&#243;n de recursos y en cuyo manejo se ven involucrados un gran n&#250;mero de profesionales sanitarios de distintas &#225;reas de la medicina que desarrollan una actividad cl&#237;nica&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Si bien la relaci&#243;n entre la enfermedad renal cr&#243;nica terminal &#40;ERCT&#41; y las enfermedades cardiovasculares es un hecho reconocido desde hace muchos a&#241;os<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">1</span></a> solo recientemente la FA ha merecido atenci&#243;n en la literatura m&#233;dica<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">2</span></a>&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Durante los &#250;ltimos a&#241;os&#44; la relaci&#243;n entre la ERCT y la FA ha ocupado un lugar creciente en las publicaciones y han aparecido numerosos estudios<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">3-7</span></a> que han analizado la prevalencia e incidencia de FA en los pacientes en di&#225;lisis&#44; con una gran variaci&#243;n en el an&#225;lisis de la prevalencia que oscila entre el 4 y el 27&#37;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">4</span></a>&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Por otro lado&#44; el evidente beneficio que el tratamiento anticoagulante ha mostrado para la prevenci&#243;n de tromboembolias en la poblaci&#243;n general no ha sido documentado en la poblaci&#243;n en di&#225;lisis&#46; Existe una gran controversia sobre el uso del tratamiento anticoagulante en la poblaci&#243;n en di&#225;lisis y su indicaci&#243;n queda sujeta a criterios individuales de los m&#233;dicos responsables del manejo de estos pacientes<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">8</span></a>&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">El objetivo de nuestro estudio es analizar la prevalencia de la FA en la poblaci&#243;n en tratamiento con hemodi&#225;lisis en Andaluc&#237;a&#44; determinar el perfil cl&#237;nico de los pacientes y la utilizaci&#243;n del tratamiento antitromb&#243;tico en la pr&#225;ctica cl&#237;nica habitual&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Pacientes y m&#233;todo</span><p id="par0030" class="elsevierStylePara elsevierViewall">Andaluc&#237;a es una comunidad con una poblaci&#243;n aproximada de 8&#46;400&#46;000 habitantes&#46; El tratamiento sustitutivo de la ERCT&#44; di&#225;lisis y trasplante&#44; est&#225; gestionado por el Servicio Andaluz de Salud&#44; que dispone de un registro de pacientes sustentado por el Sistema de Informaci&#243;n de la Coordinaci&#243;n Auton&#243;mica de Trasplantes de Andaluc&#237;a &#40;SICATA&#41;&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">En diciembre de 2014 se solicit&#243; a SICATA informaci&#243;n sobre el n&#250;mero y distribuci&#243;n por centros de los pacientes que se encontraban en tratamiento con hemodi&#225;lisis en Andaluc&#237;a&#44; tanto los que lo segu&#237;an en hospitales como en centros de di&#225;lisis extrahospitalarios&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Para el c&#225;lculo del tama&#241;o muestral se tuvo en cuenta la amplia variaci&#243;n encontrada en la prevalencia de la FA<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">4</span></a>&#46; Para conseguir una precisi&#243;n del 5&#37; en la estimaci&#243;n de una proporci&#243;n mediante un intervalo de confianza asint&#243;tico normal con correcci&#243;n para poblaciones finitas al 95&#37; bilateral&#44; asumiendo que la prevalencia esperada era hasta el 25&#37; y que el tama&#241;o total de la poblaci&#243;n era de 2&#46;348&#44; se consider&#243; apropiado incluir 285 pacientes distribuidos por los centros en funci&#243;n del n&#250;mero de pacientes tratados en cada uno de ellos&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Se contact&#243; con los nefr&#243;logos responsables de las unidades de di&#225;lisis de todos los centros de di&#225;lisis hospitalarios y extrahospitalarios de 5<span class="elsevierStyleHsp" style=""></span>de las 8<span class="elsevierStyleHsp" style=""></span>provincias de Andaluc&#237;a &#40;Almer&#237;a&#44; C&#243;rdoba&#44; Granada&#44; Ja&#233;n y M&#225;laga&#41;&#44; se les pidi&#243; su colaboraci&#243;n y se les indic&#243; el n&#250;mero de pacientes que deb&#237;an incluir en su centro&#46; Este n&#250;mero fue calculado en funci&#243;n del n&#250;mero total de pacientes que atend&#237;an en el centro&#46; Los pacientes deb&#237;an ser seleccionados por muestreo aleatorizado simple con los &#250;nicos criterios de exclusi&#243;n de ser menor de 18 a&#241;os o negarse a firmar el consentimiento informado&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">A los centros que aceptaron participar en el estudio se les solicit&#243; la realizaci&#243;n de un electrocardiograma &#40;ECG&#41; antes de iniciar la sesi&#243;n de di&#225;lisis o en la primera hora y cumplimentar un cuestionario encaminado a conocer el perfil cl&#237;nico del paciente y el tratamiento seguido y en el que se consideraba que el paciente ten&#237;a FA si en alg&#250;n momento se hab&#237;a documentado la arritmia en un registro electrocardiogr&#225;fico &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">tabla 1</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">Tanto los registros electrocardiogr&#225;ficos como los cuestionarios deb&#237;an ser remitidos al centro coordinador del estudio &#40;Complejo Hospitalario de Ja&#233;n&#41; para el an&#225;lisis del ECG y manejo centralizado de los datos&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">El ECG fue analizado por un &#250;nico observador&#44; cardi&#243;logo experimentado&#44; que recababa la opini&#243;n de un segundo cardi&#243;logo cuando lo consideraba oportuno&#46; El an&#225;lisis del registro inclu&#237;a determinaci&#243;n del ritmo&#44; trastornos de conducci&#243;n&#44; ondas Q anormales&#44; alteraciones de la repolarizaci&#243;n y medici&#243;n de ondas e intervalos&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Los primeros registros fueron obtenidos en diciembre de 2014 y los &#250;ltimos en enero de 2016&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Los patrones cl&#237;nicos de la arritmia fueron establecidos en permanente y no permanente siguiendo el mismo criterio que el del registro epidemiol&#243;gico de FA en la poblaci&#243;n espa&#241;ola &#40;estudio OFRECE&#41;<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a>&#44; que asume que es permanente cuando en el ECG realizado el d&#237;a del examen est&#225; presente la arritmia&#46; El resto de los patrones de la FA definidos como&#58; primer episodio&#44; FA parox&#237;stica&#44; FA persistente y FA persistente de larga duraci&#243;n&#44; seg&#250;n la gu&#237;a de la Sociedad Europea de Cardiolog&#237;a&#44; asumida por la Sociedad Espa&#241;ola de Cardiolog&#237;a<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">10</span></a>&#44; se han agrupado como FA no permanente siguiendo igualmente el criterio del estudio OFRECE<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a>&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Se analiz&#243; la asociaci&#243;n de FA con las caracter&#237;sticas demogr&#225;ficas&#44; perfil cl&#237;nico&#44; hallazgos electrocardiogr&#225;ficos y caracter&#237;sticas de la di&#225;lisis&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">El diagn&#243;stico de diabetes fue establecido si el paciente segu&#237;a tratamiento farmacol&#243;gico para control de glucemia y el de hipertensi&#243;n arterial si el paciente hab&#237;a seguido en alg&#250;n momento tratamiento farmacol&#243;gico hipotensor&#46; El diagn&#243;stico de accidente isqu&#233;mico transitorio &#40;AIT&#41; exig&#237;a que hubiera sido diagnosticado por un neur&#243;logo y el de accidente cerebrovascular &#40;ACV&#41; que hubiera sido&#44; adem&#225;s&#44; documentado por t&#233;cnicas de imagen&#46; Se consider&#243; que el paciente ten&#237;a enfermedad coronaria si hab&#237;a presentado un infarto agudo de miocardio o ten&#237;a estenosis significativa de arterias coronarias documentada por arteriograf&#237;a coronaria&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">Para establecer comparaciones entre los pacientes que presentaban FA y los que no la presentaban se utiliz&#243; el test de la t de Student o el no param&#233;trico de Mann-Whitney para la comparaci&#243;n de medias&#46; Para la comparaci&#243;n de variables cualitativas&#44; se utiliz&#243; el test de Chi cuadrado de Pearson&#46; Para el an&#225;lisis de la asociaci&#243;n de la FA a las distintas variables analizadas&#44; se efectu&#243; un an&#225;lisis multivariante de regresi&#243;n log&#237;stica y se obtuvieron las <span class="elsevierStyleItalic">odds ratio</span> &#40;OR&#41; y los intervalos de confianza &#40;IC&#41; del 95&#37;&#46; Para las pruebas de contraste de hip&#243;tesis&#44; un valor de p&#160;&#60;&#160;0&#44;05 fue considerado estad&#237;sticamente significativo&#46; Los an&#225;lisis fueron efectuados con el paquete estad&#237;stico SPSS para Windows&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">El estudio fue aprobado por el Comit&#233; de &#201;tica de la Investigaci&#243;n del centro coordinador del estudio y todos los pacientes firmaron el consentimiento informado de su participaci&#243;n en el estudio&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Resultados</span><p id="par0095" class="elsevierStylePara elsevierViewall">En Andaluc&#237;a hab&#237;a 4&#46;119 pacientes en tratamiento con hemodi&#225;lisis y 2&#46;348 en las 5<span class="elsevierStyleHsp" style=""></span>provincias participantes en el estudio en el momento del inicio de la inclusi&#243;n de pacientes&#46; Del tama&#241;o muestral necesario calculado para cubrir todas las estimaciones razonables de prevalencia de FA &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>285&#41;&#44; se recibieron los datos de 252 pacientes &#40;88&#44;4&#37;&#41;&#44; procedentes de 5 unidades de di&#225;lisis hospitalarias y de 19 unidades de di&#225;lisis extrahospitalarias&#46; La distribuci&#243;n de los pacientes incluidos en las provincias participantes se muestra en la <a class="elsevierStyleCrossRef" href="#fig0005">figura 1</a>&#46; La provincia de M&#225;laga fue la que aport&#243; un mayor n&#250;mero de pacientes &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>98&#41; y la de Ja&#233;n la que menos &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>26&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall">En la <a class="elsevierStyleCrossRef" href="#tbl0015">tabla 2</a> se muestran el perfil cl&#237;nico y las caracter&#237;sticas relacionadas con la di&#225;lisis de todos los pacientes incluidos&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0105" class="elsevierStylePara elsevierViewall">De los 252 pacientes incluidos en el estudio&#44; 63 &#40;25&#37;&#41; fueron diagnosticados de FA en alguno de sus patrones cl&#237;nicos de presentaci&#243;n&#46; De estos 63 pacientes&#44; 36 &#40;14&#44;3&#37; de los incluidos&#41; de FA permanente y 27 de FA no permanente &#40;42&#44;8&#37; de todos los pacientes con FA&#41;&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">Al entrar en programa de di&#225;lisis&#44; 27 pacientes &#40;10&#44;7&#37;&#41; estaban diagnosticados de FA en cualquiera de sus patrones&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">En la <a class="elsevierStyleCrossRef" href="#tbl0020">tabla 3</a> se muestra la prevalencia de la FA en relaci&#243;n con el sexo y la franja de edad de la poblaci&#243;n&#46;</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0120" class="elsevierStylePara elsevierViewall">En el an&#225;lisis univariante&#44; al analizar el perfil cl&#237;nico y los par&#225;metros electrocardiogr&#225;ficos&#44; la edad&#44; la presencia de ondas Q anormales y la duraci&#243;n de los intervalos QTc y PR &#40;PR analizado en pacientes diagnosticados de FA&#44; pero que estaban en ritmo sinusal en el registro del d&#237;a del examen&#44; es decir&#44; pacientes con FA no permanente&#41; mostraron diferencias significativas entre los diagnosticados de FA y los no diagnosticados &#40;<a class="elsevierStyleCrossRef" href="#tbl0025">tabla 4</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia><p id="par0125" class="elsevierStylePara elsevierViewall">En el an&#225;lisis de las caracter&#237;sticas de la hemodi&#225;lisis&#44; la di&#225;lisis sin heparina y el uso de heparina de bajo peso molecular como anticoagulante del circuito fueron diferentes en los pacientes con FA&#46; El tiempo en di&#225;lisis y la ganancia de peso en el intervalo corto interdi&#225;lisis estuvieron al l&#237;mite de la significaci&#243;n estad&#237;stica &#40;<a class="elsevierStyleCrossRef" href="#tbl0025">tabla 4</a>&#41;&#46;</p><p id="par0130" class="elsevierStylePara elsevierViewall">Se efectu&#243;&#44; as&#237; mismo&#44; un an&#225;lisis de las caracter&#237;sticas de la di&#225;lisis en los pacientes que hab&#237;an entrado en programa sin diagn&#243;stico de FA &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>225&#41;&#46; En este grupo&#44; los que presentaron la arritmia en el seguimiento en di&#225;lisis &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>36&#41; no mostraban diferencias respecto a los que permanecieron en ritmo sinusal &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>189&#41;&#44; en el uso de cat&#233;ter tunelizado para di&#225;lisis&#44; n&#250;mero de sesiones y horas de di&#225;lisis a la semana&#44; hemodi&#225;lisis convencional o hemodiafiltraci&#243;n y composici&#243;n del dializante &#40;concentraci&#243;n de sodio&#44; potasio&#44; calcio y bicarbonato&#41;&#46;</p><p id="par0135" class="elsevierStylePara elsevierViewall">La <a class="elsevierStyleCrossRef" href="#tbl0030">tabla 5</a> muestra las diferencias en el perfil cl&#237;nico de los pacientes diagnosticados de FA permanente y FA no permanente&#46;</p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia><p id="par0140" class="elsevierStylePara elsevierViewall">El an&#225;lisis multivariante de los pacientes que presentaron la arritmia despu&#233;s de ser incluidos en programa de di&#225;lisis muestra que mayor edad y mayor tiempo en di&#225;lisis se asociaron de forma independiente a la presencia de FA &#40;<a class="elsevierStyleCrossRef" href="#tbl0035">tabla 6</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0035"></elsevierMultimedia><p id="par0145" class="elsevierStylePara elsevierViewall">Como era previsible&#44; los pacientes con FA presentaban un riesgo tromboemb&#243;lico y un riesgo hemorr&#225;gico elevado&#44; con un <span class="elsevierStyleItalic">score Congestive heart failure&#44; Hypertension&#44; Age&#44; Diabetes&#44; Stroke&#44; Vascular disease&#44; Sex category</span> &#40;CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>VASc&#41; de 3&#44;5 y un <span class="elsevierStyleItalic">score Hypertension&#44; Abnormal renal and liver function&#44; Stroke&#44; Bleeding&#44; Labile INRs&#44; Elderly&#44; Drug or alcohol</span> &#40;HAS-BLED&#41; de 2&#44;9&#46; Solo un paciente ten&#237;a CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>VASc de 0 y 4<span class="elsevierStyleHsp" style=""></span>de 1&#46; El tratamiento utilizado en la totalidad de los pacientes y el tratamiento antitromb&#243;tico utilizado para la prevenci&#243;n de tromboembolias en los pacientes con FA se muestra en la <a class="elsevierStyleCrossRef" href="#tbl0040">tabla 7</a>&#46;</p><elsevierMultimedia ident="tbl0040"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Discusi&#243;n</span><p id="par0150" class="elsevierStylePara elsevierViewall">Los resultados de nuestro estudio muestran que la FA es un problema cl&#237;nico de primer nivel en las unidades de hemodi&#225;lisis&#46; Uno de cada 4<span class="elsevierStyleHsp" style=""></span>pacientes ha presentado la arritmia en alguno de sus patrones cl&#237;nicos y uno de cada 7<span class="elsevierStyleHsp" style=""></span>la presenta de forma permanente&#44; seg&#250;n las definiciones incluidas en el apartado de pacientes y m&#233;todo&#46;</p><p id="par0155" class="elsevierStylePara elsevierViewall">Los pacientes con FA permanente presentaban un peor perfil cardiovascular&#44; con mayor frecuencia de enfermedad coronaria y diabetes&#44; aunque esto &#250;ltimo no alcanz&#243; diferencia estad&#237;stica&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall">Nuestro estudio muestra que un alto porcentaje de pacientes inician el tratamiento sustitutivo diagnosticados de FA y que&#44; al mismo tiempo&#44; una elevada proporci&#243;n desarrollan la arritmia en el seguimiento en programa de di&#225;lisis&#46;</p><p id="par0165" class="elsevierStylePara elsevierViewall">Al comparar nuestros datos con la informaci&#243;n disponible en la literatura&#44; comprobamos una amplia variaci&#243;n en la prevalencia de la arritmia&#44; que oscila entre 4 y 27&#37;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">4</span></a>&#44; que puede ser explicada por diferencias de edad de la poblaci&#243;n analizada&#44; diferencias regionales o protocolos seguidos para establecer el diagn&#243;stico de FA&#46;</p><p id="par0170" class="elsevierStylePara elsevierViewall">La informaci&#243;n disponible en nuestro pa&#237;s proviene de estudios realizados en nuestro centro que muestran una prevalencia e incidencia en la poblaci&#243;n prevalente del 13&#44;6&#37; y de 3&#44;1&#47;100 pacientes&#47;a&#241;o de seguimiento&#44; respectivamente<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">11&#44;12</span></a> y una prevalencia e incidencia en la poblaci&#243;n que inicia di&#225;lisis del 12&#44;1&#37; y de 5&#44;9&#47;100 pacientes&#47;a&#241;o de seguimiento&#44; respectivamente<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">13</span></a>&#46; La diferencia en la prevalencia de la arritmia en el presente estudio y el realizado previamente en nuestro centro en los pacientes prevalentes<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">11</span></a> es atribuible a que el estudio de nuestro centro fue realizado al final de los a&#241;os noventa&#44; a que la poblaci&#243;n ten&#237;a una edad 5<span class="elsevierStyleHsp" style=""></span>a&#241;os inferior a la del presente an&#225;lisis y a que no fueron incluidos todos los patrones cl&#237;nicos de la enfermedad&#46;</p><p id="par0175" class="elsevierStylePara elsevierViewall">En un reciente estudio realizado en una poblaci&#243;n austriaca con un dise&#241;o similar al que estamos comentando y una mediana de edad 2<span class="elsevierStyleHsp" style=""></span>a&#241;os inferior&#44; la prevalencia de la arritmia fue del 26&#44;5&#37;&#44; muy ligeramente superior a la del presente estudio<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">14</span></a>&#46;</p><p id="par0180" class="elsevierStylePara elsevierViewall">Cuando comparamos la frecuencia de la FA en la poblaci&#243;n en di&#225;lisis con la de la poblaci&#243;n general&#44; comprobamos que la prevalencia de la arritmia es 6<span class="elsevierStyleHsp" style=""></span>veces mayor de la que presenta la poblaci&#243;n espa&#241;ola con edad igual o mayor de 40 a&#241;os<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a>&#44; con unas diferencias muy significativas en el rango de edad entre 50 y 70 a&#241;os&#44; que se aten&#250;an en la octava d&#233;cada de la vida &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0185" class="elsevierStylePara elsevierViewall">La relaci&#243;n de mayor edad y mayor prevalencia de la FA que muestra nuestro estudio es un hallazgo constante en todos los estudios&#44; tanto en la poblaci&#243;n general<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a> como en la poblaci&#243;n en di&#225;lisis&#46;</p><p id="par0190" class="elsevierStylePara elsevierViewall">Aunque la FA y la cardiopat&#237;a isqu&#233;mica comparten factores de riesgo comunes&#44; no hemos encontrado asociaci&#243;n entre enfermedad coronaria y arritmia&#46; Sin embargo&#44; en el an&#225;lisis univariante ha habido asociaci&#243;n de FA y presencia de ondas Q anormales en el ECG&#44; hallazgo que no hemos encontrado descrito con anterioridad&#46; Una posible interpretaci&#243;n podr&#237;a ser que las zonas de necrosis o fibrosis en el miocardio ventricular que representan las ondas Q anormales pueden estar igualmente presentes en el miocardio auricular y constituir el sustrato anat&#243;mico que favorece la aparici&#243;n de la arritmia&#46;</p><p id="par0195" class="elsevierStylePara elsevierViewall">La intermitencia de la hemodi&#225;lisis&#44; con los cambios bruscos del medio interno que conlleva en volemia e iones&#44; es una situaci&#243;n que puede favorecer la presentaci&#243;n de arritmias&#46; El presente estudio no evidenci&#243; relaci&#243;n entre el diagn&#243;stico de FA y las caracter&#237;sticas de la di&#225;lisis analizadas&#46;</p><p id="par0200" class="elsevierStylePara elsevierViewall">En el grupo de pacientes que fueron diagnosticados de FA despu&#233;s de entrar en programa de di&#225;lisis no hubo asociaci&#243;n de la arritmia con la t&#233;cnica de di&#225;lisis&#46; Al igual que en el nuestro&#44; en el estudio ESHOL&#44; la presencia de arritmias evaluadas por los ingresos hospitalarios o muerte por esta causa fue similar entre los pacientes en hemodiafiltraci&#243;n <span class="elsevierStyleItalic">on line</span> y los tratados con hemodi&#225;lisis est&#225;ndar&#44; a pesar de que los episodios de hipotensi&#243;n fueron menores con la t&#233;cnica convectiva<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">15</span></a>&#46;</p><p id="par0205" class="elsevierStylePara elsevierViewall">La composici&#243;n electrol&#237;tica del dializante no fue diferente en los pacientes diagnosticados de FA&#46; Aunque no existe informaci&#243;n de estudios controlados sobre la asociaci&#243;n causal de trastornos electrol&#237;ticos y FA cr&#243;nica en la poblaci&#243;n en di&#225;lisis&#44; algunos estudios han encontrado cambios electrocardiogr&#225;ficos&#44; como un intervalo QT alargado y los niveles s&#233;ricos predi&#225;lisis de potasio y calcio bajos<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">16</span></a>&#46; La relaci&#243;n entre los niveles de iones predi&#225;lisis y los del dializante no est&#225; completamente aclarada&#46; Una reciente publicaci&#243;n del estudio DOPPS muestra que la hiperpotasemia predi&#225;lisis se asocia a la presentaci&#243;n de arritmias&#44; pero no evidencia la asociaci&#243;n de arritmias con diferentes concentraciones de potasio en el dializante para cualquier nivel de potasio s&#233;rico<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">17</span></a>&#46;</p><p id="par0210" class="elsevierStylePara elsevierViewall">En un estudio espa&#241;ol&#44; aunque con distinto dise&#241;o al nuestro&#44; para una misma concentraci&#243;n de potasio en el dializante &#40;K&#58;&#160;1&#44;5&#160;mEq&#47;L&#41;&#44; los cambios del potasio s&#233;rico intradi&#225;lisis en los pacientes que presentaron arritmias fueron similares a los que experimentaron los pacientes que no las presentaron<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">7</span></a>&#44; lo que se&#241;ala que son necesarias otras condiciones&#44; posiblemente alteraciones de la estructura cardiaca&#44; para que se produzca la arritmia&#46;</p><p id="par0215" class="elsevierStylePara elsevierViewall">El perfil de riesgo tromboemb&#243;lico de los pacientes en FA determinado por la escala CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>VASc<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">18</span></a> es elevado&#44; como ocurre en la pr&#225;ctica totalidad de los estudios que analizan este aspecto&#46; En nuestro estudio puede incluso estar infravalorado&#44; ya que no hemos incluido la presencia de insuficiencia cardiaca&#44; al no disponer de ecocardiograma que estime la funci&#243;n ventricular y considerar que el diagn&#243;stico cl&#237;nico de insuficiencia cardiaca en la poblaci&#243;n en di&#225;lisis presenta dificultades en un estudio de estas caracter&#237;sticas<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">19</span></a>&#46; Este elevado perfil de riesgo se ha traducido en una mayor tasa de eventos tromboemb&#243;licos y mortalidad respecto a los pacientes en ritmo sinusal en los estudios realizados en nuestra instituci&#243;n<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">13&#44;20&#44;21</span></a>&#46; Igualmente elevado y concordante con la informaci&#243;n disponible es el riesgo hemorr&#225;gico determinado por la escala HASBLED<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">22</span></a>&#46;</p><p id="par0220" class="elsevierStylePara elsevierViewall">La decisi&#243;n de instaurar tratamiento anticoagulante en estos pacientes es uno de los temas que m&#225;s controversia ha generado en los &#250;ltimos a&#241;os<a class="elsevierStyleCrossRefs" href="#bib0260"><span class="elsevierStyleSup">23-25</span></a>&#46; Nuestro estudio muestra que el 17&#44;1&#37; de todos los pacientes en hemodi&#225;lisis en Andaluc&#237;a y m&#225;s de la mitad de los pacientes con FA estaban o hab&#237;an estado en tratamiento con derivados cumar&#237;nicos&#46; Creemos que se trata de una informaci&#243;n relevante acerca de la actitud de los cardi&#243;logos y nefr&#243;logos responsables de estos pacientes ante el problema de la prevenci&#243;n de tromboembolias en los pacientes en di&#225;lisis con FA&#46;</p><p id="par0225" class="elsevierStylePara elsevierViewall">En un estudio de dise&#241;o transversal realizado en 89 centros de hemodi&#225;lisis de Espa&#241;a que representaban el 29&#37; de los centros a nivel nacional&#44; el porcentaje de pacientes en tratamiento con anticoagulantes orales era muy parecido &#40;18&#44;4&#37;&#41; al del presente an&#225;lisis<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">26</span></a>&#46;</p><p id="par0230" class="elsevierStylePara elsevierViewall">Otro aspecto de igual transcendencia respecto al tratamiento antitromb&#243;tico es la utilizaci&#243;n de los antiagregantes en las unidades de di&#225;lisis&#46; Aunque existen recomendaciones que consideran que los pacientes con enfermedad renal cr&#243;nica se encuentran entre los grupos con mayor riesgo para presentar eventos ateroescler&#243;ticos y podr&#237;a ser razonable el uso de &#225;cido acetil salic&#237;lico en prevenci&#243;n primaria<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">27</span></a>&#44; la falta de evidencia del beneficio de esta actitud&#44; junto con el riesgo hemorr&#225;gico que conlleva<a class="elsevierStyleCrossRefs" href="#bib0285"><span class="elsevierStyleSup">28&#44;29</span></a>&#44; deber&#237;a hacer reconsiderar el uso de estos f&#225;rmacos en prevenci&#243;n primaria&#46; En el presente estudio el porcentaje de pacientes en tratamiento con uno o 2<span class="elsevierStyleHsp" style=""></span>antiagregantes era del 51&#44;1&#37;&#44; porcentaje muy similar al aportado por el estudio espa&#241;ol sobre anticoagulaci&#243;n en hemodi&#225;lisis previamente mencionado<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">26</span></a>&#46; El 23&#44;8&#37; de los pacientes con FA no ten&#237;an enfermedad vascular documentada y segu&#237;an tratamiento con antiagregantes&#46; El 62&#37; de los pacientes de nuestro estudio con esta terapia no presentaban enfermedad vascular documentada&#46; Suponemos que en el primer caso el tratamiento hab&#237;a sido indicado para la prevenci&#243;n de tromboembolias y en el segundo como prevenci&#243;n primaria&#46; Creemos que en ambas situaciones la indicaci&#243;n del tratamiento antiagregante deber&#237;a ser reconsiderada&#44; al no estar indicado para la prevenci&#243;n de tromboembolias en los pacientes con FA<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">10</span></a>&#44; no existir evidencia de su beneficio en el segundo caso y suponer un riesgo hemorr&#225;gico considerable<a class="elsevierStyleCrossRefs" href="#bib0285"><span class="elsevierStyleSup">28&#44;29</span></a>&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Limitaciones</span><p id="par0235" class="elsevierStylePara elsevierViewall">El tama&#241;o de muestra del estudio se plante&#243; para obtener una precisi&#243;n del 5&#37; en la estimaci&#243;n de una proporci&#243;n&#44; mediante un intervalo de confianza al 95&#37; bilateral&#44; teniendo en cuenta un porcentaje de p&#233;rdidas del 10&#37;&#46; Finalmente&#44; las p&#233;rdidas han sido del 11&#44;6&#37;&#44; por lo que la precisi&#243;n de la estimaci&#243;n de la proporci&#243;n en el presente estudio es de un 5&#44;04&#37;&#46;</p><p id="par0240" class="elsevierStylePara elsevierViewall">La prevalencia real de la arritmia puede estar infraestimada&#46; Los pacientes sin episodios de FA previamente documentados y que estaban en ritmo sinusal en el ECG realizado el d&#237;a de examen pod&#237;an haber presentado en alg&#250;n momento episodios no detectados&#46; Esta es una limitaci&#243;n presente en todos los estudios epidemiol&#243;gicos que analizan la FA<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a>&#46; Por otro lado&#44; el ECG fue realizado antes del inicio de la di&#225;lisis o en la primera hora&#44; cuando los cambios electrol&#237;ticos y la tasa de ultrafiltraci&#243;n son menos pronunciados&#46; En el estudio espa&#241;ol previamente mencionado la presentaci&#243;n de arritmias supraventriculares se increment&#243; a lo largo de di&#225;lisis&#44; con mayor manifestaci&#243;n en la &#250;ltima hora<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">7</span></a>&#46;</p><p id="par0245" class="elsevierStylePara elsevierViewall">Concluimos se&#241;alando que la FA es un problema relevante en las unidades de di&#225;lisis&#46;</p><p id="par0250" class="elsevierStylePara elsevierViewall">La falta de protocolos de manejo&#44; fundamentalmente en lo que respecta a la prevenci&#243;n de tromboembolias&#44; hace que las decisiones terap&#233;uticas representen un aut&#233;ntico dilema para los nefr&#243;logos y cardi&#243;logos responsables&#46; La realizaci&#243;n de estudios controlados y aleatorizados o&#44; en su defecto&#44; la elaboraci&#243;n de documentos de consenso de expertos se hace cada vez m&#225;s necesaria&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Financiaci&#243;n</span><p id="par0255" class="elsevierStylePara elsevierViewall">Trabajo financiado por el proyecto c&#243;digo PI11&#47;02275&#44; integrado en el Plan Estatal de I&#43;D&#43;i 2008-2011 del ISCIII-Subdirecci&#243;n General de Evaluaci&#243;n y Fomento de la Investigaci&#243;n y cofinanciado por el Fondo Europeo de Desarrollo Regional &#40;FEDER&#41;&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Conflicto de intereses</span><p id="par0260" class="elsevierStylePara elsevierViewall">Los autores declaran no tener conflictos de inter&#233;s&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:12 [
        0 => array:3 [
          "identificador" => "xres1090208"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objetivo"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "M&#233;todos"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1033517"
          "titulo" => "Palabras clave"
        ]
        2 => array:3 [
          "identificador" => "xres1090209"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:1 [
              "identificador" => "abst0030"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objective"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Methods"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec1033516"
          "titulo" => "Keywords"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introducci&#243;n"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Pacientes y m&#233;todo"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Resultados"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Discusi&#243;n"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Limitaciones"
        ]
        9 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Financiaci&#243;n"
        ]
        10 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Conflicto de intereses"
        ]
        11 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2017-05-31"
    "fechaAceptado" => "2017-09-11"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec1033517"
          "palabras" => array:4 [
            0 => "Insuficiencia renal cr&#243;nica terminal"
            1 => "Hemodi&#225;lisis"
            2 => "Fibrilaci&#243;n auricular"
            3 => "Tratamiento antitromb&#243;tico"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec1033516"
          "palabras" => array:4 [
            0 => "End-stage chronic kidney failure"
            1 => "Haemodialysis"
            2 => "Atrial fibrillation"
            3 => "Antithrombotic therapy"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La fibrilaci&#243;n auricular &#40;FA&#41; es un importante problema social y sanitario&#46; Existe una amplia variaci&#243;n en la prevalencia de esta arritmia en los estudios que analizan a los pacientes en hemodi&#225;lisis &#40;HD&#41;&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objetivo</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Investigar la prevalencia&#44; perfil cl&#237;nico y manejo terap&#233;utico de los pacientes con FA en HD en Andaluc&#237;a&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">M&#233;todos</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Solicitamos al sistema sanitario p&#250;blico de Andaluc&#237;a el n&#250;mero de pacientes que estaban siendo tratados con HD&#46; Pedimos a los nefr&#243;logos responsables de todos los centros hospitalarios y extrahospitalarios de 5 de las 8 provincias de Andaluc&#237;a que realizaran un electrocardiograma y cumplimentaran un cuestionario en pacientes seleccionados por un muestreo aleatorizado simple&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Resultados</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Estaban en HD 2&#46;348 pacientes en las 5<span class="elsevierStyleHsp" style=""></span>provincias incluidas&#46; El tama&#241;o muestral estimado fue 285 pacientes&#46; Obtuvimos electrocardiograma e informaci&#243;n de 252 &#40;88&#44;4&#37;&#41;&#46; Edad media 65&#44;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>16 a&#241;os&#59; 40&#44;9&#37; mujeres&#46; Ten&#237;an FA 63<span class="elsevierStyleHsp" style=""></span>pacientes &#40;25&#37;&#41;&#46; De estos&#44; 36 &#40;14&#44;3&#37;&#41; ten&#237;an FA en el registro realizado y en el resto hab&#237;a sido documentada previamente&#46; En el an&#225;lisis multivariante&#44; mayor edad &#40;OR&#58;&#160;1&#44;071&#59; IC&#160;95&#37;&#58; 1&#44;036-1&#44;107&#59; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;000&#41; y mayor tiempo en HD &#40;OR&#58;&#160;1&#44;009&#59; IC&#160;95&#37;&#58;1&#44;004-1&#44;014&#59; p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;000&#41; se asociaron de forma independiente con la FA&#46; De los pacientes con FA&#44; el 41&#44;3&#37; estaban en tratamiento anticoagulante en el momento del estudio y el 41&#44;2&#37; con antiagregantes&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusiones</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">La FA en las unidades de di&#225;lisis es un importante hallazgo&#46; Establecer la relaci&#243;n riesgo-beneficio del tratamiento anticoagulante constituye un aut&#233;ntico reto&#46; Son necesarios ensayos cl&#237;nicos bien dise&#241;ados para establecer el uso racional del tratamiento antitromb&#243;tico&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:1 [
            "identificador" => "abst0005"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objetivo"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "M&#233;todos"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Atrial fibrillation &#40;AF&#41; represents an important social and healthcare problem&#46; There is wide variability in the prevalence of this arrhythmia in studies analysing patients on haemodialysis &#40;HD&#41;&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objective</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">To investigate the prevalence&#44; clinical profile and therapeutic management of patients with AF on HD in Andalusia&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Methods</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">We asked the public healthcare system of Andalusia to provide us with the number of patients who were being treated with HD&#46; We asked attending nephrologists from all hospital and outpatient centres in 5 of the 8 Andalusian provinces to perform an electrocardiogram and to fill out a questionnaire on patients selected by simple random sampling&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Results</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">A total of 2&#44;348 patients were being treated with HD in the 5<span class="elsevierStyleHsp" style=""></span>provinces included in the study&#46; The estimated sample size was 285 patients&#46; We obtained an electrocardiogram and information from 252 patients &#40;88&#46;4&#37;&#41;&#59; mean age 65&#46;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>16 years&#59; 40&#46;9&#37; women&#46; Sixty-three patients &#40;25&#37;&#41; had AF&#46; Of these&#44; 36 &#40;14&#46;3&#37;&#41; had AF in the recorded ECG and in the rest it had been documented previously&#46; In the multivariate analysis&#44; older age &#40;OR&#58; 1&#46;071&#59; 95&#37; CI&#58; 1&#46;036-1&#46;107&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;000&#41; and greater time on HD &#40;OR&#58; 1&#46;009&#59; 95&#37;&#160;CI&#58; 1&#46;004-1&#46;014&#59; <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;000&#41; were independently associated with the presence of AF&#46; Of the patients with AF&#44; 41&#46;3&#37; were on anticoagulant treatment at the time of the study&#59; and 41&#46;2&#37; were on antiplatelet agents&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusions</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">AF in dialysis units is an important finding&#46; Establishing the risk-benefit ratio of anticoagulant treatment constitutes a real challenge&#46; Well-designed clinical trials are pivotal in order to define the rational use of antithrombotic drugs&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:1 [
            "identificador" => "abst0030"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objective"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Methods"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusions"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:3 [
        "etiqueta" => "&#9674;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Un listado completo de los miembros del grupo de investigaci&#243;n se cita en el <a class="elsevierStyleCrossRef" href="#sec0040">anexo</a></p>"
        "identificador" => "fn0005"
      ]
    ]
    "apendice" => array:1 [
      0 => array:1 [
        "seccion" => array:1 [
          0 => array:4 [
            "apendice" => "<p id="par0275" class="elsevierStylePara elsevierViewall"><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></p>"
            "etiqueta" => "Anexo"
            "titulo" => "Investigadores del estudio FAIRC ANDALUC&#205;A"
            "identificador" => "sec0040"
          ]
        ]
      ]
    ]
    "multimedia" => array:10 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1975
            "Ancho" => 3000
            "Tamanyo" => 245566
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Distribuci&#243;n de los pacientes seg&#250;n provincias y procedencia hospitalaria o extrahospitalaria&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1522
            "Ancho" => 2333
            "Tamanyo" => 146621
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Diferencias en la prevalencia de FA entre la poblaci&#243;n general&#44; estudio OFRECE<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a> y pacientes en di&#225;lisis del estudio FAIRC Andaluc&#237;a&#46; Se muestra en prevalencia total y por franjas de edad&#46;</p> <p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">El estudio OFRECE<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a> incluy&#243; poblaci&#243;n con edad igual o mayor de 40 a&#241;os&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">ACV&#58; accidente cerebrovascular&#59; AIT&#58; accidente isqu&#233;mico transitorio&#59; ARA&#58; antagonistas de los receptores de la angiotensina&#59; CERA&#58; <span class="elsevierStyleItalic">continuous erythropoietin receptor activator</span>&#59; EPO&#58; eritropoyetina&#59; HTA&#58; hipertensi&#243;n arterial&#59; IECA&#58; inhibidor de la enzima de conversi&#243;n de la angiotensina&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " colspan="3" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Se&#241;alar donde proceda</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Se hace ECG en el centro&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cuando se precisa&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cada &#8230; meses y cuando se precisa&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sexo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hombre&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Mujer&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Fecha de nacimiento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="center" valign="top">dd&#47;mm&#47;aaaa</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Fecha de inicio de di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="center" valign="top">dd&#47;mm&#47;aaaa</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Nefropat&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Glomerulonefritis&#59; pielonefritis&#44; diabetes&#59; nefroangioesclerosis&#59; poliquistosis&#59; enfermedad familiar&#59; enfermedad sist&#233;mica&#59; no filiada&#46; Otras</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Diabetes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Insulina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;HTA antes de entrar en di&#225;lisis&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Di&#225;lisis peritoneal previa&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Trasplante renal previo&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">&#191;Ha presentado el paciente enfermedad coronaria documentada por haber tenido un infarto o por tener hecha coronariograf&#237;a que muestre lesiones&#63;</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antes de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Despu&#233;s de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">&#191;Ha presentado el paciente un ACV isqu&#233;mico documentado por Neurolog&#237;a o Medicina Interna&#63;</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antes de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Despu&#233;s de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">&#191;Ha presentado el paciente un AIT documentado por Neurolog&#237;a&#63;</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antes de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Despu&#233;s de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">&#191;Ha presentado el paciente un ACV hemorr&#225;gico documentado por TAC o RMN&#63;</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antes de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Despu&#233;s de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">&#191;Tiene el paciente alguna amputaci&#243;n de miembros inferiores por enfermedad arterial perif&#233;rica</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top">Independientemente del ritmo actual&#44; &#191;se ha documentado alg&#250;n episodio de fibrilaci&#243;n auricular en alg&#250;n momento&#63;</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antes de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Despu&#233;s de entrar en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hemodi&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Convencional&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hemodiafiltraci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Acceso vascular&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">F&#237;stula&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cat&#233;ter&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">N&#46;&#176; de hemodi&#225;lisis a la semana&#58; N&#250;mero de horas&#47;semana&#58;</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">Heparina s&#243;dica&#47;heparina de bajo PM&#47;ninguna</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Concentrado de di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Sodio&#59; potasio&#44; calcio&#59; bicarbonato &#40;mEq&#47;L&#41;</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ganancia de peso en las 3 &#250;ltimas di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Fin de semana &#40;viernes a lunes&#59; s&#225;bado a martes&#41;&#58;<br>2&#46;<span class="elsevierStyleSup">a</span> &#40;lunes a mi&#233;rcoles&#59; martes a jueves&#41;&#58;<br>3&#46;<span class="elsevierStyleSup">a</span> &#40;mi&#233;rcoles a viernes&#59; jueves a s&#225;bados&#41;&#58;</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="center" valign="top">Estimulantes de la eritropoyesis&#58; EPO&#59; darbepoetina&#59; CERA&#59; ninguno</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Aspirina&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Clopidogrel&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Acenocumarol o warfarina en la actualidad&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Ha tomado acenocumarol o warfarina en alg&#250;n momento desde que est&#225; en di&#225;lisis aunque ahora no lo tome&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Protectores g&#225;stricos&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Omeprazol&#47; otros inhibidores de la bomba de protones&#47;rantidina&#47;ninguno</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;IECA&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;ARA&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Calcioantagonistas&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Amlodipino&#59; diltiazem&#59; verapamil&#59; otros&#59; ninguno</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antiarr&#237;tmicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Amiodarona&#59; flecainida&#59; propafenona&#59; otros&#59; ninguno</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Betabloqueantes&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " colspan="2" align="left" valign="top">Atenolol&#59; bisoprolol&#59; carvedilol&#59; otro&#59; ninguno</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Digoxina&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191; Estatinas&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Resin calcio&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">S&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Quelantes del f&#243;sforo&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">C&#225;lcicos&#59; no c&#225;lcicos&#59; Ninguno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#191;Vitamina D&#63; &#191;Cinacalcet&#63;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Calcitriol&#59; paricalcitol&#59; cinacalcet&#59; otros&#59; ninguno&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863991.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Cuestionario dirigido a establecer el perfil cl&#237;nico de los pacientes&#44; las caracter&#237;sticas de hemodi&#225;lisis y el tratamiento seguido</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0015"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0100" class="elsevierStyleSimplePara elsevierViewall">ACV&#58; accidente cerebrovascular&#59; AIT&#58; accidente isqu&#233;mico transitorio&#59; HTA&#58; hipertensi&#243;n arterial&#59; PM&#58; peso molecular&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edad &#40;a&#241;os&#41;&#59; rango&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">65&#44;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>16&#44;8 &#40;21-93&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edad &#40;a&#241;os&#41;&#58; mediana &#40;intervalo intercuart&#237;lico&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">68&#44;5 &#40;53&#44;1-78&#44;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hombres&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">149 &#40;59&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Diabetes n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">96 &#40;38&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">HTA&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">213 &#40;84&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Trasplante previo&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">48 &#40;19&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ACV o AIT n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27 &#40;10&#44;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ACV hemorr&#225;gico n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5 &#40;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Enfermedad coronaria n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50 &#40;19&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Amputaci&#243;n no traum&#225;tica de miembros inferiores n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8 &#40;3&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Portador de marcapasos n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3 &#40;1&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Di&#225;lisis hospitalaria&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">110 &#40;43&#44;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tiempo en di&#225;lisis &#40;meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">68&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>74&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hemodiafiltraci&#243;n&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">45 &#40;17&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Di&#225;lisis 3 d&#237;as a la semana&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">238 &#40;94&#44;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cat&#233;ter tunelizado&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">68 &#40;27&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Anticoagulaci&#243;n en di&#225;lisis&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">226 &#40;89&#44;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Heparina de bajo PM&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">165 &#40;65&#44;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dializante&#58; sodio&#8805; 140 mEq&#47;l&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">176 &#40;69&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dializante&#58; potasio&#8805; 2 mEq&#47;l&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">146 &#40;57&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dializante&#58; calcio&#8805; 3 mEq&#47;l&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">198 &#40;78&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dializante&#58; CO<span class="elsevierStyleInf">3</span>H <span class="elsevierStyleSup">&#8722;</span> &#8805; 35 mEq&#47;l&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">103 &#40;40&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Estimulantes de la eritropoyesis&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">203 &#40;80&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Resin calcio&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">59 &#40;23&#44;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Quelantes del f&#243;sforo&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">166 &#40;65&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Quelantes del f&#243;sforo c&#225;lcicos&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">77 &#40;30&#44;5&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vitamina D&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">96 &#40;38&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cinacalcet&#44; n &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52 &#40;20&#44;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863995.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Perfil cl&#237;nico y caracter&#237;sticas de la di&#225;lisis de todos los pacientes incluidos en el an&#225;lisis &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>252&#41;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Grupo de edad&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Todos &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>252&#41; n&#47;N &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Mujeres &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>103&#41; n&#47;N &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hombres &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>149&#41; n&#47;N &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#60; 50 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#47;49 &#40;4&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#47;17 &#40;5&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#47;32 &#40;3&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">50-59 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7&#47;36 &#40;19&#44;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#47;14 &#40;7&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&#47;22 &#40;27&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">60-69 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#47;50 &#40;22&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#47;15 &#40;13&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&#47;35 &#40;25&#44;7&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">70-79 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">22&#47;63 &#40;34&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#47;31 &#40;25&#44;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#47;32 &#40;43&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#8805; 80 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21&#47;54 &#40;38&#44;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&#47;26 &#40;46&#44;15&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&#47;28 &#40;32&#44;1&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Todos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&#47;252 &#40;25&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24&#47;103 &#40;23&#44;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">39&#47;149 &#40;26&#44;2&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863996.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">Distribuci&#243;n de la fibrilaci&#243;n auricular seg&#250;n sexo y franja de edad</p>"
        ]
      ]
      5 => array:8 [
        "identificador" => "tbl0025"
        "etiqueta" => "Tabla 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0115" class="elsevierStyleSimplePara elsevierViewall">ACV&#58; accidente cerebrovascular&#59; AIT&#58; accidente isqu&#233;mico transitorio&#59; HTA&#58; hipertensi&#243;n arterial&#59; PM&#58; peso molecular&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">FA &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>63&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">No FA &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>189&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edad en a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">73&#44;3<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>11&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">62&#44;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hombres en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">58&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;605&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tiempo en di&#225;lisis &#40;meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">82&#44;9<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>84&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>69&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;067&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Di&#225;lisis en el hospital en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">44&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;660&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Trasplante renal previo en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;175&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Diabetes en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">36&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">38&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;765&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">HTA antes o despu&#233;s de entrar en di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">85&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">84&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;763&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Enfermedad coronaria antes o despu&#233;s de di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;101&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ACV isqu&#233;mico antes o despu&#233;s de di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#44;8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;198&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ACV hemorr&#225;gico antes o despu&#233;s de di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;794&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Amputaci&#243;n no traum&#225;tica de extremidades inferiores en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;407&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hipertrofia ventricular izquierda &#40;Sokolow o Cornell&#41; en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;414&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ondas Q anormales en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">29&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ondas T negativas en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;662&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Bloqueo de rama completo en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;503&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Marcapasos en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;314&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duraci&#243;n QRS &#40;ms&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">103<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">102<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>20&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;675&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duraci&#243;n QTc &#40;ms&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">449<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">436<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;012&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duraci&#243;n PR &#40;pacientes en ritmo sinusal en el momento del registro&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">183<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>49&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">170<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>26&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;027&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cat&#233;ter tunelizado en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hemodiafiltraci&#243;n en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">18&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Sesiones de di&#225;lisis&#58; 3 d&#237;as&#47;semana en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">93&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">94&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Na<span class="elsevierStyleSup">&#43;&#43;</span> concentrado dial&#46; &#8805; 140 mEq&#47;l en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">62&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">72&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">K<span class="elsevierStyleSup">&#43;</span> concentrado dial&#46; &#8805; 2 mEq&#47;l en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">60&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">57&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ca<span class="elsevierStyleSup">&#43;&#43;</span> concentrado dial&#46; &#8805; 3&#160;mEq&#47;l en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">79&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">78&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">CO<span class="elsevierStyleInf">3</span>H<span class="elsevierStyleSup">-</span> concentrado dial&#46; &#8805; 35 mEq&#47;l en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">40&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ganancia de peso fin de semana &#40;g&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#46;488<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>920&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#46;719<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>1&#46;045&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ganancia de peso periodo corto &#40;g&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#46;888<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>874&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#46;133<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>980&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;06&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Di&#225;lisis sin anticoagulaci&#243;n del circuito en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Di&#225;lisis con heparina de bajo PM en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">70&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;011&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Agentes eritropoy&#233;ticos en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">76&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">82&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Resin calcio en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">22&#44;8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;66&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Quelantes del f&#243;sforo en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">69&#44;8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">64&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Quelantes del f&#243;sforo c&#225;lcicos en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vitamina D en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">40&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cinacalcet en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863997.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0110" class="elsevierStyleSimplePara elsevierViewall">Diferencias en el perfil cl&#237;nico y caracter&#237;sticas de la di&#225;lisis entre los pacientes con o sin diagn&#243;stico de FA</p>"
        ]
      ]
      6 => array:8 [
        "identificador" => "tbl0030"
        "etiqueta" => "Tabla 5"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at5"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0125" class="elsevierStyleSimplePara elsevierViewall">ACV&#58; accidente cerebrovascular&#59; AIT&#58; accidente isqu&#233;mico transitorio&#59; HTA&#58; hipertensi&#243;n arterial&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="" valign="top" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">FA permanente &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>36&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">FA no permanente &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>27&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sin FA &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>189&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">&#42;</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edad en a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">74&#44;23<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>10&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">72&#44;4<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>12&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">62&#44;6<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>17&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;511&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hombres en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">62&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">58&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;921&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tiempo en di&#225;lisis &#40;meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">86&#44;9<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>81&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">79&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>88&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">63&#44;1<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>69&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;716&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Trasplante renal previo en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">18&#44;8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;482&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Diabetes en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">45&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">38&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;160&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">HTA antes o despu&#233;s de entrar en di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">87&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">83&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">84&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;681&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Enfermedad coronaria antes o despu&#233;s de di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">12&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;009&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ACV isqu&#233;mico antes o despu&#233;s de di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;535&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ACV hemorr&#225;gico antes o despu&#233;s de di&#225;lisis en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;321&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Amputaci&#243;n no traum&#225;tica de extremidades inferiores en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;306&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hipertrofia ventricular izquierda &#40;Sokolow o Cornell&#41; en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;122&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ondas Q anormales en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;470&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Bloqueo de rama completo en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">11&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;862&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duraci&#243;n QRS &#40;ms&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">103<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>22&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">103<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>23&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">102<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>20&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;904&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Duraci&#243;n QTc &#40;ms&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">451<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>36&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">447<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>36&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">436<span class="elsevierStyleHsp" style=""></span>&#177;<span class="elsevierStyleHsp" style=""></span>30&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;764&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Di&#225;lisis en el hospital en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&#44;9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">40&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">44&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;916&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cat&#233;ter tunelizado en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">29&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">28&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;936&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Agentes eritropoy&#233;ticos en &#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">80&#44;8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">67&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">82&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;266&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863994.png"
              ]
            ]
          ]
          "notaPie" => array:1 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "&#42;"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Diferencias entre FA permanente y no permanente&#46;</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0120" class="elsevierStyleSimplePara elsevierViewall">Diferencias en las caracter&#237;sticas cl&#237;nicas de los diagnosticados de FA permanente vs&#46; FA no permanente</p>"
        ]
      ]
      7 => array:8 [
        "identificador" => "tbl0035"
        "etiqueta" => "Tabla 6"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at6"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0135" class="elsevierStyleSimplePara elsevierViewall">Variables introducidas en el an&#225;lisis&#58; edad&#59; sexo&#59; tiempo en di&#225;lisis&#59; di&#225;lisis en hospital&#59; presencia de diabetes&#44; hipertensi&#243;n arterial&#44; enfermedad coronaria&#44; ACV isqu&#233;mico&#59; tipo de acceso vascular&#59; ganancia de peso interdi&#225;lisis periodo corto&#59; ganancia de peso fin de semana&#59; di&#225;lisis con concentrado de Na&#160;&#8805;&#160;140 mEq&#47;l&#59; concentrado de Ca&#160;&#8805;&#160;3&#160;mEq&#47;&#59; concentrado de K&#160;&#8805;&#160;2&#160;mEq&#47;l&#59; concentrado de bicarbonato &#8805;&#160;35&#160;mEq&#47;l&#59; tratamiento con resin calcio&#44; vitamina D&#44; cinacalcet&#44; cualquier quelante del f&#243;sforo y estimulantes de la EPO&#59; presencia de ondas Q anormales en el ECG&#44; hipertrofia de ventr&#237;culo izquierdo y duraci&#243;n del QTc&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">OR&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">IC&#160;95&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Edad&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;071&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;036-1&#44;107&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Tiempo en di&#225;lisis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;009&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1&#44;004-1&#44;014&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#44;000&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863993.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0130" class="elsevierStyleSimplePara elsevierViewall">Relaci&#243;n entre las variables cl&#237;nicas&#44; variables relacionadas con la di&#225;lisis y par&#225;metros electrocardiogr&#225;ficos con la presencia de fibrilaci&#243;n auricular</p>"
        ]
      ]
      8 => array:8 [
        "identificador" => "tbl0040"
        "etiqueta" => "Tabla 7"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at7"
            "detalle" => "Tabla "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0145" class="elsevierStyleSimplePara elsevierViewall">ARA&#58; antagonistas de los receptores de la angiotensina&#59; FA&#58; fibrilaci&#243;n auricular&#59; IECA&#58; inhibidor de la enzima de conversi&#243;n de la angiotensina&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Tratamiento farmacol&#243;gico utilizado en la totalidad de la muestra analizada &#40;n<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>252&#41; en &#37;</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#193;cido acetil salic&#237;lico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">46&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Clopidogrel&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Doble antiagregaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Acenocumarol o warfarina en el momento del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14&#44;2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Acenocumarol o warfarina en alg&#250;n momento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#44;1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Inhibidores de bomba de protones&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">79&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ranitidina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">IECA o ARA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">40&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Estatinas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">53&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Betabloqueantes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">37&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Antiarr&#237;tmicos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#44;6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Digoxina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2&#44;4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="center" valign="top">Tratamiento antitromb&#243;tico en los pacientes con FA</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&#193;cido acetil salic&#237;lico&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">31&#44;7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Clopidogrel&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9&#44;5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Acenocumarol o warfarina en el momento del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">41&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Acenocumarol o warfarina en alg&#250;n momento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52&#44;3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863992.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="spar0140" class="elsevierStyleSimplePara elsevierViewall">Tratamiento farmacol&#243;gico utilizado en la totalidad de la muestra analizada y tratamiento antitromb&#243;tico utilizado para la prevenci&#243;n de tromboembolias en los pacientes con fibrilaci&#243;n auricular</p>"
        ]
      ]
      9 => array:5 [
        "identificador" => "tbl0005"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => false
        "mostrarDisplay" => true
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Provincia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Centro&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Investigador&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Almer&#237;a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complejo Hospitalario Torrec&#225;rdenas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Remedios Gar&#243;fano L&#243;pez&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hospital de Poniente&#46; El Ejido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sergio Garc&#237;a Marcos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis FMC Los Arcos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Dolores S&#225;nchez Torres&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Hu&#233;rcal-Overa&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Juan Francisco Requena Soriano&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">C&#243;rdoba&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis FMC Cabra&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Fco&#46; Javier Ariza Fuentes<br>Soledad Gallardo Valle&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis FMC Pintor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Fco&#46; Javier Ariza Fuentes<br>M&#46; Jes&#250;s Moreno Rubio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis FMC San Rafael&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Isabel Berdud Godoy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Perpetuo Socorro&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#46; Antonia &#193;lvarez de Lara<br>Mateo Alc&#225;ntara Crespo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Ntra&#46; Sra&#46; de Bel&#233;n&#46; Palma del R&#237;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Victoria Eugenia Garc&#237;a Montemayor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Granada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hospital Universitario Virgen de las Nieves&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pilar Galindo Sacrist&#225;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Carmen de Gracia Guindo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Nevada&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#46; Jos&#233; Torres S&#225;nchez&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Guadix&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#46; Carmen Ruiz Fuentes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ja&#233;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complejo Hospitalario de Ja&#233;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#46; Jos&#233; Garc&#237;a Cort&#233;s&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Santa Catalina&#46; Diaverum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#46; del Mar Biechy Bald&#225;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Nefrolinares&#46; Linares&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Miguel &#193;ngel Garc&#237;a P&#233;rez&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">M&#225;laga&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Hospital Regional Universitario&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Teresa V&#225;zquez S&#225;nchez<br>Lara Perea Ortega&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Ayala&#46; Diaverum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Tamara Jim&#233;nez Salcedo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Torremolinos&#46; Diaverum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Luis Cerme&#241;o Marv&#237;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis de la Axarqu&#237;a&#46; Diaverum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Antonio Romero Alc&#225;ntara&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis FMC Ciudad Jard&#237;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Seema Sujan&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis FMC El C&#243;nsul&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#46; Victoria Moreno Mu&#241;oz<br>Jes&#250;s Ruiz Alaminos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Braun&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Elena Vaquero P&#225;rrizas<br>Lourdes Blanca Martos<br>Edisson Rudas Berm&#250;dez&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Centro de Di&#225;lisis Hospital Quir&#243;n&#46; Marbella&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">N&#233;stor Oliva D&#225;maso&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1863990.png"
              ]
            ]
          ]
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:29 [
            0 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical epidemiology of cardiovascular disease in chronic renal disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46;N&#46; Foley"
                            1 => "P&#46;S&#46; Parfrey"
                            2 => "M&#46;J&#46; Sarnak"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis&#46;"
                        "fecha" => "1998"
                        "volumen" => "32"
                        "numero" => "suppl 3"
                        "paginaInicial" => "184"
                        "paginaFinal" => "199"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atrial fibrillation in dialysis patients&#58; A neglected comorbidity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M&#46;G&#46; Atta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2010121250"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "203"
                        "paginaFinal" => "205"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21289210"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The increasing prevalence of auricular fibrillation among hemodialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "W&#46;C&#46; Winkelmayer"
                            1 => "A&#46;R&#46; Patrick"
                            2 => "J&#46; Liu"
                            3 => "M&#46;A&#46; Brookhart"
                            4 => "S&#46; Setoguchi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2010050459"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol&#46;"
                        "fecha" => "2011"
                        "volumen" => "22"
                        "paginaInicial" => "349"
                        "paginaFinal" => "357"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21233416"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systematic review and meta-analysis of incidence&#44; prevalence and outcomes of auricular fibrillation in patients on dialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "D&#46; Zimmerman"
                            1 => "M&#46;M&#46; Sood"
                            2 => "C&#46; Rigatto"
                            3 => "R&#46;M&#46; Holden"
                            4 => "S&#46; Hiremath"
                            5 => "C&#46;M&#46; Clase"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfs416"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2012"
                        "volumen" => "27"
                        "paginaInicial" => "3816"
                        "paginaFinal" => "3822"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23114904"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Increased risk of auricular fibrillation in end-stage renal disease patients on dialysis&#58; A nationwide&#44; population-based study in Taiwan"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46;H&#46; Shen"
                            1 => "C&#46;M&#46; Zheng"
                            2 => "K&#46;T&#46; Kiu"
                            3 => "H&#46;A&#46; Chen"
                            4 => "C&#46;C&#46; Wu"
                            5 => "K&#46;C&#46; Lu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/MD.0000000000003933"
                      "Revista" => array:5 [
                        "tituloSerie" => "Medicine &#40;Baltimore&#41;&#46;"
                        "fecha" => "2016"
                        "volumen" => "95"
                        "paginaInicial" => "e3933"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27336884"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Standardized prevalence ratios for atrial fibrillation in adult dialysis patients in Japan"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Ohsawa"
                            1 => "K&#46; Tanno"
                            2 => "T&#46; Okamura"
                            3 => "Y&#46; Yonekura"
                            4 => "K&#46; Kato"
                            5 => "Y&#46; Fujishima"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2188/jea.JE20150077"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Epidemiol&#46;"
                        "fecha" => "2016 5"
                        "volumen" => "26"
                        "paginaInicial" => "272"
                        "paginaFinal" => "276"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26804038"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Asymptomatic intradialytic supraventricular arrhythmias and adverse outcomes in patients on hemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Verde"
                            1 => "A&#46; P&#233;rez de Prado"
                            2 => "J&#46;M&#46; L&#243;pez-G&#243;mez"
                            3 => "B&#46; Quiroga"
                            4 => "M&#46; Goicoechea"
                            5 => "A&#46; Garc&#237;a-Prieto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2215/CJN.04310416"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin J Am Soc Nephrol&#46;"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "paginaInicial" => "2210"
                        "paginaFinal" => "2217"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27697781"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Meta-Analysis of anticoagulation use&#44; stroke&#44; thromboembolism&#46; Bleeding&#44; and mortality in patients with atrial fibrillation on dialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "C&#46;X&#46; Wong"
                            1 => "A&#46; Odutayo"
                            2 => "C&#46;A&#46; Emdin"
                            3 => "N&#46;J&#46; Kinnear"
                            4 => "M&#46;T&#46; Sun"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjcard.2016.03.042"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Cardiol&#46;"
                        "fecha" => "2016"
                        "volumen" => "117"
                        "paginaInicial" => "1934"
                        "paginaFinal" => "1941"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27237624"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "OFRECE study collaborators&#46; Prevalencia de fibrilaci&#243;n auricular en Espa&#241;a&#46; Resultados del estudio OFRECE"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;J&#46; G&#243;mez-Doblas"
                            1 => "J&#46; Mu&#241;iz"
                            2 => "J&#46;J&#46; Martin"
                            3 => "G&#46; Rodr&#237;guez-Roca"
                            4 => "J&#46;M&#46; Lobos"
                            5 => "P&#46; Awamleh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.rec.2013.07.014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Esp Cardiol&#46;"
                        "fecha" => "2014"
                        "volumen" => "67"
                        "paginaInicial" => "259"
                        "paginaFinal" => "269"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24774588"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:1 [
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "2016 ESC Guidelines for the management of auricular fibrillation developed in collaboration with EACTS"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Kirchhof"
                            1 => "S&#46; Benussi"
                            2 => "D&#46; Kotecha"
                            3 => "A&#46; Ahlsson"
                            4 => "D&#46; Atar"
                            5 => "B&#46; Casadei"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/eurheartj/ehw210"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Heart J&#46;"
                        "fecha" => "2016"
                        "volumen" => "37"
                        "paginaInicial" => "2893"
                        "paginaFinal" => "2962"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27567408"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Influence of auricular fibrillation on the morbido-mortality of patients on hemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; V&#225;zquez"
                            1 => "C&#46; S&#225;nchez-Perales"
                            2 => "F&#46; Borrego"
                            3 => "M&#46;J&#46; Garc&#237;a-Cort&#233;s"
                            4 => "C&#46; Lozano"
                            5 => "M&#46; Guzm&#225;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am Heart J&#46;"
                        "fecha" => "2000"
                        "volumen" => "140"
                        "paginaInicial" => "886"
                        "paginaFinal" => "890"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11099992"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0205"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Incidencia de la fibrilaci&#243;n auricular en los pacientes en hemodi&#225;lisis&#46; Estudio prospectivo a largo plazo"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:5 [
                            0 => "E&#46; V&#225;zquez Ruiz de Castroviejo"
                            1 => "C&#46; S&#225;nchez Perales"
                            2 => "C&#46; Lozano Cabezas"
                            3 => "M&#46;J&#46; Garc&#237;a Cort&#233;s"
                            4 => "M&#46; Guzm&#225;n Herrera"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Esp Cardiol&#46;"
                        "fecha" => "2006"
                        "volumen" => "59"
                        "paginaInicial" => "779"
                        "paginaFinal" => "784"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16938226"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0210"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atrial fibrillation in incident dialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; V&#225;zquez"
                            1 => "C&#46; S&#225;nchez-Perales"
                            2 => "F&#46; Garc&#237;a-Garc&#237;a"
                            3 => "P&#46; Castellano"
                            4 => "M&#46;J&#46; Garc&#237;a-Cortes"
                            5 => "A&#46; Liebana"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2009.185"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2009"
                        "volumen" => "76"
                        "paginaInicial" => "324"
                        "paginaFinal" => "330"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19494800"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0215"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "e0169400&#44; eCollection 2017"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence of atrial fibrillation and antithrombotic&#46; Therapy in hemodialysis patients&#58; Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patientes on HemoDIalysis &#40;VIVALDI&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "O&#46; Koenigsbruegge"
                            1 => "F&#46; Posch"
                            2 => "M&#46; Antlanger"
                            3 => "J&#46; Kovarik"
                            4 => "R&#46; Klauser-Braun"
                            5 => "J&#46; Kletzmayr"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal.pone.0169400"
                      "Revista" => array:4 [
                        "tituloSerie" => "PLoS One"
                        "fecha" => "2017"
                        "volumen" => "12"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29287100"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0220"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "High-efficiency posdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "ESHOL Study Group"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Maduell"
                            1 => "F&#46; Moreso"
                            2 => "M&#46; Pons"
                            3 => "R&#46; Ramos"
                            4 => "J&#46; Mora-Maci&#224;"
                            5 => "J&#46; Carreras"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1681/ASN.2012080875"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Soc Nephrol"
                        "fecha" => "2013"
                        "volumen" => "24"
                        "paginaInicial" => "487"
                        "paginaFinal" => "497"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23411788"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0225"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Electrocardiographic abnormalities and QTc interval in patients undergoing hemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "Y&#46; Nie"
                            1 => "J&#46; Zou"
                            2 => "Y&#46; Liang"
                            3 => "B&#46; Shen"
                            4 => "Z&#46; Liu"
                            5 => "X&#46; Cao"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1371/journal"
                      "Revista" => array:5 [
                        "tituloSerie" => "PLoS ONE"
                        "fecha" => "2016"
                        "volumen" => "11"
                        "paginaInicial" => "e0155445"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27171393"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0230"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Dialysate potassium&#44; serum potassium&#46; mortality&#44; and arrhythmia events in hemodialysis&#58; Results from the Dialysis Outcomes and Practice Patterns Study &#40;DOPPS&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:5 [
                            0 => "A&#46; Karaboyas"
                            1 => "J&#46; Zee"
                            2 => "S&#46;M&#46; Brunelli"
                            3 => "L&#46;A&#46; Usvyat"
                            4 => "D&#46;E&#46; Weiner"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2016.09.015"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis&#46;"
                        "fecha" => "2017"
                        "volumen" => "69"
                        "paginaInicial" => "266"
                        "paginaFinal" => "277"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27866964"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0235"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Refining clinical risk stratification for predicting stroke and thromboembolism in auricular fibrillation using a novel risk factor-based approach"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "G&#46;Y&#46;H&#46; Lip"
                            1 => "R&#46; Nieuwlaat"
                            2 => "R&#46; Pisters"
                            3 => "D&#46;A&#46; Lane"
                            4 => "H&#46;J&#46; Crijns"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1378/chest.09-1584"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest&#46;"
                        "fecha" => "2010"
                        "volumen" => "137"
                        "paginaInicial" => "263"
                        "paginaFinal" => "272"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19762550"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0240"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Is there something special about ischemic heart disease in patients undergoing dialysis&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "C&#46;A&#46; Herzog"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ahj.2003.12.025"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am Heart J&#46;"
                        "fecha" => "2004"
                        "volumen" => "147"
                        "paginaInicial" => "942"
                        "paginaFinal" => "944"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15199336"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0245"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ischaemic stroke in incident dialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; S&#225;nchez-Perales"
                            1 => "E&#46; V&#225;zquez"
                            2 => "M&#46;J&#46; Garc&#237;a-Cort&#233;s"
                            3 => "J&#46; Borrego"
                            4 => "M&#46; Polaina"
                            5 => "C&#46;P&#46; Guti&#233;rrez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfq220"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2010"
                        "volumen" => "25"
                        "paginaInicial" => "3343"
                        "paginaFinal" => "3348"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20466665"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0250"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of prognostic value of auricular fibrillation versus sinus rhythm in patients on long-term hemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; V&#225;zquez"
                            1 => "C&#46; S&#225;nchez-Perales"
                            2 => "C&#46; Lozano"
                            3 => "M&#46;J&#46; Garc&#237;a-Cort&#233;s"
                            4 => "F&#46; Borrego"
                            5 => "M&#46; Guzm&#225;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Cardiol&#46;"
                        "fecha" => "2003"
                        "volumen" => "92"
                        "paginaInicial" => "868"
                        "paginaFinal" => "877"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14516897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0255"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A novel user-friendly score &#40;HAS-BLED&#41; to assess 1-year risk of major bleeding in patients with auricular fibrillation&#58; The Euro Heart Survey"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "R&#46; Pisters"
                            1 => "D&#46;A&#46; Lane"
                            2 => "R&#46; Nieuwlaat"
                            3 => "C&#46;B&#46; de Vos"
                            4 => "H&#46;J&#46; Crijns"
                            5 => "G&#46;Y&#46; Lip"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1378/chest.10-0134"
                      "Revista" => array:6 [
                        "tituloSerie" => "Chest&#46;"
                        "fecha" => "2010"
                        "volumen" => "138"
                        "paginaInicial" => "1093"
                        "paginaFinal" => "1100"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20299623"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0260"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sailing between Scylla and Charybdis&#58; Oral long-term anticoagulation in dialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "T&#46; Kr&#252;ger"
                            1 => "V&#46; Brandenburg"
                            2 => "G&#46; Schlieper"
                            3 => "N&#46; Marx"
                            4 => "J&#46; Floege"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/ndt/gfs485"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nephrol Dial Transplant&#46;"
                        "fecha" => "2013"
                        "volumen" => "28"
                        "paginaInicial" => "534"
                        "paginaFinal" => "541"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23180880"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib0265"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "Epub 2016 Dec 9"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nuevos anticoagulantes orales en pacientes con enfermedad renal cr&#243;nica&#46; &#91;art&#237;culo en espa&#241;ol e ingl&#233;s&#93;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "L&#46; Belmar Vega"
                            1 => "A&#46;L&#46; de Francisco"
                            2 => "J&#46; Bada da Silva"
                            3 => "L&#46; Galv&#225;n Espinoza"
                            4 => "G&#46; Fern&#225;ndez Fresnedo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.nefro.2016.08.006"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrolog&#237;a&#46;"
                        "fecha" => "2017"
                        "volumen" => "37"
                        "paginaInicial" => "244"
                        "paginaFinal" => "252"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27939514"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib0270"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Warfarin treatment in patients with auricular fibrillation and advanced chronic kidney disease&#58; Sins of omission or commission&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "W&#46;C&#46; Winkelmayer"
                            1 => "M&#46;P&#46; Turakhia"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/jama.2014.1781"
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA&#46;"
                        "fecha" => "2014"
                        "volumen" => "311"
                        "paginaInicial" => "913"
                        "paginaFinal" => "915"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24595773"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib0275"
              "etiqueta" => "26"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estudio espa&#241;ol sobre anticoagulaci&#243;n en hemodi&#225;lisis"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "en representaci&#243;n del Grupo de Estudio Espa&#241;ol Sobre Anticoagulaci&#243;n en Hemodi&#225;lisis"
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;A&#46; Herrero-Calvo"
                            1 => "E&#46; Gonz&#225;lez-Parra"
                            2 => "R&#46; P&#233;rez-Garc&#237;a"
                            3 => "F&#46; Tornero-Molina"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3265/Nefrologia.pre2011.Nov.11106"
                      "Revista" => array:6 [
                        "tituloSerie" => "Nefrologia"
                        "fecha" => "2012"
                        "volumen" => "32"
                        "paginaInicial" => "143"
                        "paginaFinal" => "152"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22425796"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib0280"
              "etiqueta" => "27"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical practice guidelines for cardiovascular disease in dialysis patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "K&#47;DOQI"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Am J Kidney Dis&#46;"
                        "fecha" => "2005"
                        "volumen" => "45"
                        "numero" => "suppl 3"
                        "paginaInicial" => "S1"
                        "paginaFinal" => "S154"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15806502"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib0285"
              "etiqueta" => "28"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Major bleeding events and risk stratification of antithrombotic agents in hemodialysis&#58; Results from the DOPPS"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46;M&#46; Sood"
                            1 => "M&#46; Larkina"
                            2 => "J&#46;R&#46; Thumma"
                            3 => "F&#46; Tentori"
                            4 => "B&#46;W&#46; Gillespie"
                            5 => "S&#46; Fukuhara"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/ki.2013.170"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int&#46;"
                        "fecha" => "2013"
                        "volumen" => "84"
                        "paginaInicial" => "600"
                        "paginaFinal" => "608"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23677245"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib0290"
              "etiqueta" => "29"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bleeding risk of antithrombotic treatment in patients on hemodialysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; V&#225;zquez"
                            1 => "C&#46; S&#225;nchez-Perales"
                            2 => "S&#46; Ortega"
                            3 => "T&#46; V&#225;zquez-S&#225;nchez"
                            4 => "E&#46; Quesada"
                            5 => "D&#46; Salas"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/FJC.0000000000000460"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Cardiovasc Pharmacol&#46;"
                        "fecha" => "2017"
                        "volumen" => "69"
                        "paginaInicial" => "192"
                        "paginaFinal" => "197"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28375903"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02116995/0000003800000003/v2_201810040615/S021169951730187X/v2_201810040615/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "42448"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003800000003/v2_201810040615/S021169951730187X/v2_201810040615/es/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951730187X?idApp=UINPBA000064"
]
Compartir